
Jagadishwar Rao Samala
Examiner (ID: 8163, Phone: (571)272-9927 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618 |
| Total Applications | 1215 |
| Issued Applications | 815 |
| Pending Applications | 79 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7225204
[patent_doc_number] => 20050255080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-11-17
[patent_title] => 'Magic bullets and anti - slip'
[patent_app_type] => utility
[patent_app_number] => 10/844464
[patent_app_country] => US
[patent_app_date] => 2004-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 362
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20050255080.pdf
[firstpage_image] =>[orig_patent_app_number] => 10844464
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/844464 | Magic bullets and anti - slip | May 12, 2004 | Abandoned |
Array
(
[id] => 5084856
[patent_doc_number] => 20070274907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-29
[patent_title] => 'Magnetically Targetable Mitomycin C Compositions and Methods of Their Use'
[patent_app_type] => utility
[patent_app_number] => 10/593045
[patent_app_country] => US
[patent_app_date] => 2004-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 18118
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20070274907.pdf
[firstpage_image] =>[orig_patent_app_number] => 10593045
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/593045 | Magnetically Targetable Mitomycin C Compositions and Methods of Their Use | May 11, 2004 | Abandoned |
Array
(
[id] => 7033171
[patent_doc_number] => 20050031680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-10
[patent_title] => 'In vivo use of water absorbent polymers'
[patent_app_type] => utility
[patent_app_number] => 10/840112
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5908
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20050031680.pdf
[firstpage_image] =>[orig_patent_app_number] => 10840112
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/840112 | In vivo use of water absorbent polymers | May 5, 2004 | Issued |
Array
(
[id] => 5699674
[patent_doc_number] => 20060216358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Controlled release composition containing a strontium salt'
[patent_app_type] => utility
[patent_app_number] => 10/556150
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 20798
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216358.pdf
[firstpage_image] =>[orig_patent_app_number] => 10556150
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/556150 | Controlled release composition containing a strontium salt | May 5, 2004 | Abandoned |
Array
(
[id] => 7200519
[patent_doc_number] => 20050042289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Tablets and methods for modified release of hydrophylic and other active agents'
[patent_app_type] => utility
[patent_app_number] => 10/835214
[patent_app_country] => US
[patent_app_date] => 2004-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12600
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042289.pdf
[firstpage_image] =>[orig_patent_app_number] => 10835214
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/835214 | Tablets and methods for modified release of hydrophylic and other active agents | Apr 27, 2004 | Abandoned |
Array
(
[id] => 6966091
[patent_doc_number] => 20050232988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Orally disintegrating tablets and methods of manufacture'
[patent_app_type] => utility
[patent_app_number] => 10/827106
[patent_app_country] => US
[patent_app_date] => 2004-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6155
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20050232988.pdf
[firstpage_image] =>[orig_patent_app_number] => 10827106
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/827106 | Orally disintegrating tablets and methods of manufacture | Apr 18, 2004 | Issued |
| 10/823435 | Medical devices employing polymers of specific characteristics and their uses | Apr 11, 2004 | Abandoned |
Array
(
[id] => 7038805
[patent_doc_number] => 20050158239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-21
[patent_title] => 'Perturbed membrane-binding compounds and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/799586
[patent_app_country] => US
[patent_app_date] => 2004-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13909
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20050158239.pdf
[firstpage_image] =>[orig_patent_app_number] => 10799586
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/799586 | Perturbed membrane-binding compounds and methods of using the same | Mar 14, 2004 | Issued |
Array
(
[id] => 8232355
[patent_doc_number] => 08197793
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-06-12
[patent_title] => 'Methods of radiofluorination of biologically active vectors'
[patent_app_type] => utility
[patent_app_number] => 10/549082
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9348
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/197/08197793.pdf
[firstpage_image] =>[orig_patent_app_number] => 10549082
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/549082 | Methods of radiofluorination of biologically active vectors | Mar 11, 2004 | Issued |
Array
(
[id] => 7168509
[patent_doc_number] => 20050202050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Single tank process for preparing tannate liquid and semi-solid dosage forms'
[patent_app_type] => utility
[patent_app_number] => 10/799302
[patent_app_country] => US
[patent_app_date] => 2004-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2640
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0202/20050202050.pdf
[firstpage_image] =>[orig_patent_app_number] => 10799302
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/799302 | Single tank process for preparing tannate liquid and semi-solid dosage forms | Mar 11, 2004 | Abandoned |
Array
(
[id] => 7418538
[patent_doc_number] => 20040228797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-18
[patent_title] => 'Compositions for use in embolizing blood vessels comprising high levels of contrast agent'
[patent_app_type] => new
[patent_app_number] => 10/796604
[patent_app_country] => US
[patent_app_date] => 2004-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6918
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20040228797.pdf
[firstpage_image] =>[orig_patent_app_number] => 10796604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/796604 | Compositions for use in embolizing blood vessels comprising high levels of contrast agent | Mar 7, 2004 | Abandoned |
Array
(
[id] => 7462506
[patent_doc_number] => 20040166152
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Use of buckysome or carbon nanotube for drug delivery'
[patent_app_type] => new
[patent_app_number] => 10/790153
[patent_app_country] => US
[patent_app_date] => 2004-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13564
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20040166152.pdf
[firstpage_image] =>[orig_patent_app_number] => 10790153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/790153 | Use of buckysome or carbon nanotube for drug delivery | Feb 29, 2004 | Abandoned |
Array
(
[id] => 7147869
[patent_doc_number] => 20040170563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Magnetic resonance imaging agents for the delivery of therapeutic agents'
[patent_app_type] => new
[patent_app_number] => 10/789840
[patent_app_country] => US
[patent_app_date] => 2004-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17465
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20040170563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10789840
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/789840 | Magnetic resonance imaging agents for the delivery of therapeutic agents | Feb 26, 2004 | Abandoned |
Array
(
[id] => 917219
[patent_doc_number] => 07323444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-01-29
[patent_title] => 'Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis'
[patent_app_type] => utility
[patent_app_number] => 10/546758
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3915
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/323/07323444.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546758
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546758 | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | Feb 25, 2004 | Issued |
Array
(
[id] => 4999265
[patent_doc_number] => 20070041899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Radiolabelled substrates'
[patent_app_type] => utility
[patent_app_number] => 10/546656
[patent_app_country] => US
[patent_app_date] => 2004-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2327
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20070041899.pdf
[firstpage_image] =>[orig_patent_app_number] => 10546656
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/546656 | Radiolabelled substrates | Feb 25, 2004 | Abandoned |
Array
(
[id] => 7372616
[patent_doc_number] => 20040219227
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-04
[patent_title] => 'Gentle-acting skin-disinfectants and hydroalcoholic gel formulations'
[patent_app_type] => new
[patent_app_number] => 10/786681
[patent_app_country] => US
[patent_app_date] => 2004-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14085
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20040219227.pdf
[firstpage_image] =>[orig_patent_app_number] => 10786681
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/786681 | Gentle-acting skin-disinfectants and hydroalcoholic gel formulations | Feb 24, 2004 | Abandoned |
Array
(
[id] => 281844
[patent_doc_number] => 07553844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-06-30
[patent_title] => 'Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/783268
[patent_app_country] => US
[patent_app_date] => 2004-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 6
[patent_no_of_words] => 7297
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/553/07553844.pdf
[firstpage_image] =>[orig_patent_app_number] => 10783268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/783268 | Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors | Feb 19, 2004 | Issued |
Array
(
[id] => 5632573
[patent_doc_number] => 20060149043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Fluorescent lanthadine complex'
[patent_app_type] => utility
[patent_app_number] => 10/536382
[patent_app_country] => US
[patent_app_date] => 2004-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 5820
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0149/20060149043.pdf
[firstpage_image] =>[orig_patent_app_number] => 10536382
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/536382 | Fluorescent lanthadine complex | Feb 16, 2004 | Issued |
Array
(
[id] => 5807326
[patent_doc_number] => 20060093680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Coated particles and pharmaceutical dosage forms'
[patent_app_type] => utility
[patent_app_number] => 10/544920
[patent_app_country] => US
[patent_app_date] => 2004-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14364
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093680.pdf
[firstpage_image] =>[orig_patent_app_number] => 10544920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/544920 | Coated particles and pharmaceutical dosage forms | Feb 10, 2004 | Abandoned |
Array
(
[id] => 373390
[patent_doc_number] => 07473693
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-06
[patent_title] => 'Stable dispersion of solid particles comprising a water-insoluble pyrazine compound'
[patent_app_type] => utility
[patent_app_number] => 10/543264
[patent_app_country] => US
[patent_app_date] => 2004-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14667
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/473/07473693.pdf
[firstpage_image] =>[orig_patent_app_number] => 10543264
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/543264 | Stable dispersion of solid particles comprising a water-insoluble pyrazine compound | Feb 1, 2004 | Issued |